Navigation Links
Researcher Receives Free Flow Cytometer System as First Winner of Accuri(R) Flow Cytometer Creativity Awards Program

-Accuri Is Awarding a Free Bench-Top Flow Cytometer System Twice Yearly to Support Innovative Research and Expand the Use of Flow Cytometry-

-Learn More about the Revolutionary Accuri C6 Flow Cytometer at the American Society for Cell Biology Annual Meeting-

ANN ARBOR, Mich., Dec. 11 /PRNewswire/ -- Accuri Cytometers Inc., a life sciences company developing revolutionary bench-top flow cytometer systems, today announced the first recipient of its Accuri Flow Cytometer Creativity Awards program. Heather Newkirk, Ph.D., Executive Director of Business Development and Quality Assurance/Regulatory Affairs at Clinical Reference Laboratory, Inc. and an Assistant Professor of Medicine at the University of Missouri-Kansas City, will receive a free Accuri C6 Flow Cytometer(R) System. Accuri's twice-yearly Creativity Awards program was created to foster innovative research that taps the unrealized potential of flow cytometry and expands its use to novel applications that are newly possible as a result of the unique capabilities of the Accuri C6 system.

(Photo: )

Explicitly designed for routine use by biomedical researchers in their own labs, Accuri's C6 Flow Cytometer is a full-featured bench-top cell analysis system that provides capabilities similar to industry leaders in a more user-friendly format and at a fraction of the cost of other flow cytometers.

"We are gratified by the quality and creativity of this first group of research proposals for our Creativity Awards program," said Grant Howes, an industry veteran who recently joined Accuri as Director of Marketing. "A key driver behind the development of the C6 system was our belief that the research power of flow cytometry has been hampered by its lack of wide accessibility. The diverse and imaginative responses to the first round of our Awards program provide concrete evidence that our accessible, affordable flow cytometer system can help unleash the full potential of flow cytometry."

Accuri designed the revolutionary C6 system from the ground up with input from hundreds of researchers who use flow cytometry, and it specially commissioned the easy-to-use cell analysis software that is a critical component of the approach. Accuri's innovations, coupled with its state-of-the-art components, result in a cytometer that is powerful, robust, compact and affordable, at less than one-third the cost of the current market leader.

Dr. Newkirk, the recipient of the first C6 Flow Cytometer System awarded by Accuri's Creativity Awards program, plans to use bead-based assays to detect direct genomic translocations, an approach that could be applied to a myriad of genomic rearrangements, including detecting specific translocations in certain cancers. She noted, "Flow cytometry offers researchers the chance to innovate in the design of a variety of assays, and I am excited by the opportunity to develop new assays to be performed on the C6 flow cytometer. It is encouraging to see that flow cytometry has been translated into a user-friendly, lower-cost system with the invention of the C6."

Dr. Newkirk will receive her C6 system early in 2009. It will be hers to keep, along with a year-long warranty as part of the award.

Jennifer Baird, CEO of Accuri, commented, "We are delighted to announce our first Accuri Flow Cytometer Creativity Awards winner. Dr. Newkirk's genomics research proposal is a fitting illustration of why we believe that the versatility and accessibility of our flow cytometer system will generate innovative research and a host of creative applications. We congratulate her and her team and look forward to seeing the fruits of their research, as well as many more proposals from researchers around the globe."

Learn more about the Accuri C6 Flow Cytometer System and the company's next upcoming Creativity Awards grant by visiting Booth 2023 at the 48th Annual Meeting of the American Society for Cell Biology in San Francisco from December 13-17, 2008, or at Accuri Cytometers: Cell Analysis Within Reach(R).

About Accuri Cytometers

Accuri Cytometers, Inc. is an Ann Arbor-based life sciences company developing and marketing revolutionary high performance cell analysis systems designed to bring the power of flow cytometry into the labs of life sciences researchers everywhere. Reflecting the input of hundreds of researchers, the Accuri C6 Flow Cytometer(R) is a full-featured bench-top cell and bead analysis system that provides similar capabilities to those of industry-leading flow cytometers in an easy-to-use format and at a fraction of their cost. The Accuri system was engineered from the start to be compact, powerful and user-friendly, while also being affordable by most research laboratories. For more information, visit

About Clinical Reference Laboratory

Established in 1979, Clinical Reference Laboratory, Inc. offers leading-edge testing services in the areas of Molecular Diagnostics, Clinical Trials, Toxicology, Insurance and Wellness testing. With a comprehensive test menu ranging from routine laboratory services to the latest in molecular testing, we are committed to providing high-quality science with a human touch. For more information, visit

    For additional information, contact:
    Accuri Cytometers
    Jack Ball
    Chief Commercial Officer
    (734) 994-8000

    GendeLLindheim BioCom Partners
    Barbara Lindheim
    (212) 918-4650

SOURCE Accuri Cytometers Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Children of depressed moms do better when dad is involved, SLU researcher finds
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
5. Bipolar disorder relapses halved by Melbourne researchers
6. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
7. High and mighty: first common height gene identified by researchers behind obesity gene finding
8. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
9. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
10. Researchers develop long-lasting growth hormone
11. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
Post Your Comments:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for physicians and athletic programs, launches new Wimbledon Athletics Facebook page ... testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under the age ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... board certified facial plastic surgeon specializing in both surgical and non-surgical treatments, announced ... Skin Spa at Hobgood Facial Plastic Surgery. , Highly trained and nationally ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... “While riding ... an inventor, from Bronx, N.Y. “I thought there had to be a convenient and ... the PROTECTOR. , The PROTECTOR enables disabled individuals to safely travel during cold or ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... cancer, I found that regular bras were incredibly uncomfortable," said an inventor from ... specialized bra." , She developed the patent-pending RECOVERY BRA for added comfort and ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a non-profit organization devoted to ... raising public awareness of the disorder while helping to bring expert medical care ... to bolster progress at the Tuberous Sclerosis Complex Center at Ann & Robert ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... plc (NYSE: AGN ) today announced that it has ... Attorney General,s Office to end the litigation under ... the Attorney General over the decision of Forest Laboratories, Inc., ... now generic version of memantine immediate release tablets.  Under the ... counterclaims against New York , and has ...
(Date:11/25/2015)... 2015 Allergan plc (NYSE: AGN ... Therapeutics, a start-up  biotechnology company focused on the ... and funded by the F-Prime Biomedical Research Initiative ... an exclusive collaboration to support the discovery and ... (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... November 25, 2015 --> ... blood glucose devices was valued at $11,171.1 million in ... CAGR of 5.7% during 2015 - 2022. The global ... increasing prevalence of diabetes. In addition, the increase in ... also contributing to the growth of the market. Furthermore, ...
Breaking Medicine Technology: